
    
      Purpose: To evaluate the safety and efficacy of THV-9300 for patients who have severe
      symptomatic aortic stenosis attributed to calcification and degeneration of a valve leaflet
      and for whom undergoing a surgery safely would be difficult.

      Follow-up: Subject data collection will include clinical information at baseline and during
      the index procedure. Subjects will undergo clinical follow-up at discharge, 30 days, 6 months
      and annually for 5 years.
    
  